Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Tygacil
DRUG
2 trials
Sponsors
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions
Bacterial Infections
Intra-Abdominal Infection
Peritonitis
Pneumonia, Bacterial
Skin Diseases, Bacterial
Skin Diseases, Infectious
Phase 2
Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age
Completed
NCT00488345
Wyeth is now a wholly owned subsidiary of Pfizer
Bacterial Infections, Intra-Abdominal Infection, Pneumonia, Bacterial +2
Start: 2007-12-31
End: 2009-09-30
Updated: 2012-10-24
Unknown Phase
Health Economic Assessment of Tygacil® in the Treatment of Secondary Peritonitis in Intensive Care Units (ICUs)
Completed
NCT00481962
Wyeth is now a wholly owned subsidiary of Pfizer
Peritonitis
Start: 2006-02-28
End: 2008-12-31
Updated: 2009-09-28
Related Papers
Pharmacokinetics and safety profile of tigecycline in children aged 8 to 11 years with selected serious infections: a multicenter, open-label, ascending-dose study.
2012-01-16
42 citations